KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inseego (INSG) Asset Writedowns and Impairment (2016 - 2025)

Inseego's Asset Writedowns and Impairment history spans 14 years, with the latest figure at -$2.0 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment fell 723.58% year-over-year to -$2.0 million; the TTM value through Dec 2025 reached -$1.6 million, down 267.79%, while the annual FY2025 figure was -$1.6 million, 2861.11% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was -$2.0 million at Inseego, down from $384000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $6.8 million in Q3 2023 and bottomed at -$2.0 million in Q4 2025.
  • The 5-year median for Asset Writedowns and Impairment is $311000.0 (2021), against an average of $708800.0.
  • The largest annual shift saw Asset Writedowns and Impairment surged 15354.55% in 2023 before it tumbled 723.58% in 2025.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $311000.0 in 2021, then surged by 859.81% to $3.0 million in 2022, then tumbled by 89.88% to $302000.0 in 2023, then increased by 5.3% to $318000.0 in 2024, then tumbled by 723.58% to -$2.0 million in 2025.
  • Per Business Quant, the three most recent readings for INSG's Asset Writedowns and Impairment are -$2.0 million (Q4 2025), $384000.0 (Q1 2025), and $318000.0 (Q4 2024).